Newsletter
Newsletter Support JNS

Study: Nearly half of Israelis agree Iran nuke sites should be attacked even without US support

The survey by the Israel Democracy Institute also found that less than a third of Jewish Israelis want the next government to advance the two-state solution with the Palestinians.

Iran Nuclear
Ali Akbar Salehi, head of Iran’s Atomic Energy Organization, shows then-President Hassan Rouhani models of nuclear centrifuges, April 9, 2019. Credit: Iranian President’s Office.

Forty-nine percent of all Israelis, and 55% of those who are Jewish, strongly or somewhat agree that Israel should attack Iranian nuclear sites even without U.S. support, according to a survey by the Israel Democracy Institute.

The study also found that less than a third of Jewish Israelis (31%) want the next government in Jerusalem to advance the two-state solution as a means of resolving the conflict with the Palestinians. A full 36% of Israelis, including 58% of Jews, do not want this paradigm to be promoted following the Jewish state’s Nov. 1 elections (11% of Jewish Israelis said they were unsure how the next government should proceed).

Regarding the upcoming Jewish New Year, which begins on Sunday at sundown, 29% of Israelis believe that next year will be better than the previous one; 30% think it will be about the same; 21% believe it will be worse; and 20% said that they don’t know.

The survey of 605 men and women interviewed in Hebrew and 149 in Arabic was conducted on the internet and by telephone between Sept. 18 and Sept. 20, 2022, and has a margin of error of 3.59 at a confidence level of 95%.

Despite making up about 10% of New Yorkers, Jews were the targets of 58% of all “reported” hate crimes in the Big Apple last month, according to city data.
Ambassador Michel Issa warned that implementing the June framework requires careful work to protect civilians.
Two members of the trip-hop group displayed an unauthorized emblem during a concert, which prompted a police investigation.
Rather than target amyloid plaques, the potential new treatment aims to restore immune functions that naturally decline with age.